Review on comparative efficacy of bevacizumab, panitumumab and cetuximab antibody therapy with combination of FOLFOX-4 in KRAS-mutated colorectal cancer patients.
about
Review on comparative efficacy of bevacizumab, panitumumab and cetuximab antibody therapy with combination of FOLFOX-4 in KRAS-mutated colorectal cancer patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Review on comparative efficacy ...... ed colorectal cancer patients.
@en
Review on comparative efficacy ...... ed colorectal cancer patients.
@nl
type
label
Review on comparative efficacy ...... ed colorectal cancer patients.
@en
Review on comparative efficacy ...... ed colorectal cancer patients.
@nl
prefLabel
Review on comparative efficacy ...... ed colorectal cancer patients.
@en
Review on comparative efficacy ...... ed colorectal cancer patients.
@nl
P2093
P2860
P921
P356
P1433
P1476
Review on comparative efficacy ...... ed colorectal cancer patients.
@en
P2093
Francesco Marotta
Hong Zhang
Jose Sollano
Madhumala Gopinath
Ramachandran Murugesan
Surajit Pathak
Sushmitha S
Xiao-Feng Sun
P2860
P304
P356
10.18632/ONCOTARGET.22471
P407
P577
2017-11-16T00:00:00Z